ClinicalTrials.gov
ClinicalTrials.gov Menu

Xarelto [SPAF] Post-marketing Surveillance in Japan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01582737
Recruitment Status : Active, not recruiting
First Posted : April 23, 2012
Last Update Posted : May 8, 2018
Sponsor:
Collaborator:
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 31, 2019
  Estimated Study Completion Date : March 31, 2019